YDES
YD Bio·NASDAQ
--
--(--)
--
--(--)
YDES fundamentals
During Q2 2025, YD Bio (YDES) reported revenue of --, a YoY change of 0.00%. Net income was -2.21M, a YoY change of -112.95%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | TTM |
|---|
Start Date | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | -- |
End Date | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | -- -- | 344.22K -- | 220.35K -- | 458.67K -- | 591.57K -- | 451.77K +31.24% | 985.09K +347.06% | 101.90K -77.78% | 523.63K -11.48% | 712.53K +57.72% | 890.13K -9.64% | 303.33K +197.69% | 369.95K -29.35% | 506.73K -28.88% | 1.05M +17.63% | 537.41K +77.17% | 260.08K -29.70% | 381.29K -24.75% | 353.82K -66.21% | 389.19K -27.58% | 1.38M -- |
Selling, General and Administrative Expenses | -- -- | 344.22K -- | -- -- | -- -- | -- -- | 1.72M +400.36% | -- -- | -- -- | -- -- | 2.32M +34.88% | -- -- | 303.33K -- | 369.95K -- | 506.73K -78.19% | 1.05M -- | 537.41K +77.17% | 260.08K -29.70% | 381.29K -24.75% | 353.82K -66.21% | 389.19K -27.58% | 1.38M -- |
Other Operating Expenses | -- -- | -- -- | 220.35K -- | 458.67K -- | 591.57K -- | -1.27M -- | 985.09K +347.06% | 101.90K -77.78% | 523.63K -11.48% | -1.61M -26.76% | 890.13K -9.64% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -- -- | -344.22K -- | -220.35K -- | -458.67K -- | -591.57K -- | -451.77K -31.24% | -985.09K -347.06% | -101.90K +77.78% | -523.63K +11.48% | -712.53K -57.72% | -890.13K +9.64% | -303.33K -197.69% | -369.95K +29.35% | -506.73K +28.88% | -1.05M -17.63% | -537.41K -77.17% | -260.08K +29.70% | -381.29K +24.75% | -353.82K +66.21% | -389.19K +27.58% | -1.38M -- |
Non-Operating Income (Loss) | -- -- | -2.19M -- | 6.00M -- | -1.13M -- | 3.79M -- | 1.76M +180.41% | 3.55M -40.75% | 912.51K +181.01% | 1.99M -47.62% | -338.50K -119.19% | 237.58K -93.31% | -1.20M -231.70% | -679.70K -134.21% | 1.18M +449.52% | -20.96M -8923.63% | 17.65M +1568.38% | 2.44M +458.65% | 799.08K -32.46% | -3.01M +85.63% | -1.83M -110.35% | -1.60M -- |
Gain (Loss) on Change in Fair Value | -- -- | -1.81M -- | -- -- | -- -- | -- -- | 10.38M +674.19% | -- -- | -- -- | -- -- | 5.92M -42.92% | -- -- | -1.35M -- | -846.25K -- | 1.02M -82.86% | -21.13M -- | 17.48M +1390.71% | 2.30M +372.05% | 677.00K -33.33% | -3.05M +85.58% | -1.86M -110.65% | -1.93M -- |
Other Non-Operating Income (Loss) | -- -- | -386.14K -- | 6.00M -- | -1.13M -- | 3.79M -- | -8.61M -2130.95% | 3.55M -40.75% | 912.51K +181.00% | 1.99M -47.64% | -6.26M +27.31% | 169.25K -95.24% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -- -- | -178 -- | -478 -- | -209 -- | -76 -- | -1 +99.44% | -- -- | -- -- | -813 -969.74% | 0 +100.00% | -68.33K -- | -152.18K -- | -166.55K -20385.49% | -167.64K -- | -169.58K -148.19% | -170.99K -12.36% | -135.54K +18.62% | -122.08K +27.18% | -34.56K +79.62% | -34.58K +79.78% | -326.75K -- |
Interest Income | -- -- | 178 -- | 478 -- | 209 -- | 76 -- | 1 -99.44% | -- -- | -- -- | 813 +969.74% | 0 -100.00% | 68.33K -- | 152.18K -- | 166.55K +20385.49% | 167.64K -- | 169.58K +148.19% | 170.99K +12.36% | 135.54K -18.62% | 122.08K -27.18% | 34.56K -79.62% | 34.58K -79.78% | 326.75K -- |
Pretax Income From Continuing Operations | 0 -- | -2.54M -- | 5.78M -- | -1.59M -- | 3.20M -- | 1.31M +151.70% | 2.57M -55.55% | 810.61K +151.14% | 1.46M -54.29% | -1.05M -180.11% | -652.55K -125.41% | -1.51M -285.68% | -1.05M -171.75% | 676.42K +164.36% | -22.01M -3272.91% | 17.11M +1236.75% | 2.18M +307.47% | 417.79K -38.23% | -3.37M +84.71% | -2.22M -112.95% | -2.99M -- |
Income Tax Expense | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 3.71K -- | -1.63K -- | 1.71K -- | 5.15K -- | 26.94K +625.14% | -15.63K -861.13% | 5.78K +238.09% | 6.26K +21.65% | -12.04K -144.70% | -- -- | 1.75K -69.63% | -1.68K -126.85% | -- -- |
Current Income Tax | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 2.09K -- | -- -- | -- -- | -- -- | 18.17K +769.75% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | -70.26K -- | -- -- | -- -- | -- -- | -267.40K -280.60% | -- -- | -- -- | -- -- | -284.67K -6.46% | -- -- | -- -- | -- -- | -226.96K +20.27% | -- -- | -- -- | -- -- | -794.95K -250.26% | -- -- | -- -- | -- -- |
Income Tax Adjustments | -- -- | 70.26K -- | -- -- | -- -- | -- -- | 267.40K +280.60% | -- -- | -- -- | -- -- | 284.67K +6.46% | -- -- | -- -- | -- -- | 226.96K -20.27% | -- -- | -- -- | -- -- | 794.95K +250.26% | -- -- | -- -- | -- -- |
Net Income | 0 -- | -2.54M -- | 5.78M -- | -1.59M -- | 3.20M -- | 1.31M +151.70% | 2.57M -55.55% | 810.61K +151.14% | 1.46M -54.41% | -1.05M -179.98% | -654.26K -125.48% | -1.51M -286.32% | -1.08M -173.78% | 692.04K +165.95% | -22.02M -3264.98% | 17.10M +1232.46% | 2.19M +303.40% | 417.79K -39.63% | -3.37M +84.70% | -2.21M -112.95% | -2.97M -- |
Net Income Attributable to Owners of the Company | -- -- | -2.54M -- | 5.78M -- | -1.59M -- | 3.20M -- | 1.31M +151.70% | 2.57M -55.55% | 810.61K +151.14% | 1.46M -54.41% | -1.05M -179.98% | -654.26K -125.48% | -1.51M -286.32% | -1.08M -173.78% | 692.04K +165.95% | -22.02M -3264.98% | 17.10M +1232.46% | 2.19M +303.40% | 417.79K -39.63% | -3.37M +84.70% | -2.21M -112.95% | -2.97M -- |
Net Income Attributable to Common Stockholders | -- -- | -2.54M -- | 5.78M -- | -1.59M -- | 3.20M -- | 1.31M +151.70% | 2.57M -55.55% | 810.61K +151.14% | 1.46M -54.41% | -1.05M -179.98% | -654.26K -125.48% | -1.51M -286.32% | -1.08M -173.78% | 692.04K +165.95% | -22.02M -3264.98% | 17.10M +1232.46% | 2.19M +303.40% | 417.79K -39.63% | -3.37M +84.70% | -2.21M -112.95% | -2.97M -- |
Other Comprehensive Income | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -2.54M -- | -- -- | -- -- | -- -- | 8.70M +442.99% | -- -- | -- -- | -- -- | 3.79M -56.48% | -- -- | -1.51M -- | -1.08M -- | 692.04K -81.73% | -22.02M -- | 17.10M +1232.46% | 2.19M +303.40% | 417.79K -39.63% | -3.37M +84.70% | -2.21M -112.95% | -2.97M -- |
Basic EPS | -- -- | -0.17 -- | 0.39 -- | -0.11 -- | 0.22 -- | 0.09 +152.94% | 0.18 -53.85% | 0.08 +172.73% | 0.2 -9.09% | -0.22 -344.44% | -0.14 -177.78% | -0.35 -537.50% | -0.25 -225.00% | 0.16 +172.73% | -5.12 -3557.14% | 4.05 +1257.14% | 0.54 +316.00% | 0.1 -37.50% | -0.98 +80.86% | -0.65 -116.05% | -0.99 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -5.12 -- | 4.05 -- | -- -- | -- -- | -0.98 +80.86% | -0.65 -116.05% | -- -- |
Diluted EPS | -- -- | -- -- | 0.39 -- | -0.11 -- | 0.22 -- | -- -- | 0.18 -53.85% | 0.08 +172.73% | 0.2 -9.09% | -- -- | -0.14 -177.78% | -0.35 -537.50% | -0.25 -225.00% | -- -- | -5.12 -3557.14% | 4.05 +1257.14% | 0.54 +316.00% | -- -- | -0.98 +80.86% | -0.65 -116.05% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -5.12 -- | 4.05 -- | -- -- | -- -- | -0.98 +80.86% | -0.65 -116.05% | -- -- |
You can ask Aime
What guidance did YD Bio's management provide for the next earnings period?What were the key takeaways from YD Bio's earnings call?What factors drove the changes in YD Bio's revenue and profit?What does YD Bio do and what are its main business segments?What were the key takeaways from YD Bio’s earnings call?What is the market's earnings forecast for YD Bio next quarter?What is YD Bio's latest dividend and current dividend yield?What is the revenue and EPS growth rate for YD Bio year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
